retatrutide clinical trial weight loss results First phase 3 data, a Triumph of Science! Dr. Tara Narula breaks down

Researchers from NYU Langone Health and NYC Health + Hospitals discovered patients who had one of the bariatric procedures lost an average 58 pounds after two years compared to 12 pounds for patients who received a GLP-1 prescription for at least six months (24% total weight loss vs

If you're an adult with a BMI that's greater than 30 or a BMI of 27 with one or more obesity-related medical issues, you should qualify for GLP-1 Treatments, Semaglutide or Tirzepatide

Ipamorelin activates the ghrelin receptor through a cortisol-sparing pathway enhancing recovery and sleep

About this article Cite this article Docimo, S., Shah, J., Warren, G